# High-dose Chemotherapy With Autologous Stem Cell Rescue in Pediatric High-risk Brain Tumors

> **NCT00798811** · PHASE2 · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Brain Tumor

## Interventions

- **PROCEDURE:** high-dose chemotherapy and autologous stem cell rescue
- **PROCEDURE:** high-dose chemotherapy and autologous stem cell rescue
- **PROCEDURE:** high-dose chemotherapy and autologous stem cell rescue

## Key facts

- **NCT ID:** NCT00798811
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-09
- **Primary completion:** 2019-12
- **Final completion:** 2021-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-03-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00798811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00798811, "High-dose Chemotherapy With Autologous Stem Cell Rescue in Pediatric High-risk Brain Tumors". Retrieved via AI Analytics 2026-08-24 from https://api.ai-analytics.org/clinical/NCT00798811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*